Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir Drug Interaction and Efficacy in HIV/HCV Coinfection
NCT01565889Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Mar 2012
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sofosbuvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Mar 2012; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01565889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01565889.